PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.53%
Revenue growth above 1.5x 3088.T's 1.41%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
4.70%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
33.61%
EBIT growth above 1.5x 3088.T's 0.35%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
19.88%
Positive operating income growth while 3088.T is negative. John Neff might view this as a competitive edge in operations.
11.98%
Net income growth above 1.5x 3088.T's 5.33%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
11.99%
EPS growth above 1.5x 3088.T's 5.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
11.99%
Diluted EPS growth above 1.5x 3088.T's 5.28%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Share reduction while 3088.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3088.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while 3088.T stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.19%
10Y revenue/share CAGR 1.25-1.5x 3088.T's 30.16%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
49.64%
5Y revenue/share CAGR above 1.5x 3088.T's 2.54%. David Dodd would look for consistent product or market expansions fueling outperformance.
23.37%
Positive 3Y CAGR while 3088.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.11%
Below 50% of 3088.T's 140.86%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
35.31%
Positive 5Y CAGR while 3088.T is negative. John Neff might view this as a strong mid-term relative advantage.
27.80%
Positive short-term CAGR while 3088.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
180.29%
10Y equity/share CAGR 1.25-1.5x 3088.T's 129.35%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
118.59%
5Y equity/share CAGR above 1.5x 3088.T's 40.21%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
55.15%
3Y equity/share CAGR above 1.5x 3088.T's 16.23%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-0.48%
Inventory is declining while 3088.T stands at 2.63%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.68%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.68%
Positive BV/share change while 3088.T is negative. John Neff sees a clear edge over a competitor losing equity.
-50.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.98%
We expand SG&A while 3088.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.